Bhagirath B. Solanki, Christine Juergens, Manojkumar B. Chopada, Pravin Supe, Vani Sundaraiyer, Natacha Le Dren-Narayanin, . . . Beate Schmoele-Thoma. (2017). Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial. Taylor & Francis Group.
Chicago Style (17th ed.) CitationBhagirath B. Solanki, et al. Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Adults 50 to 65 years of Age in India: An Open-label Trial. Taylor & Francis Group, 2017.
MLA (9th ed.) CitationBhagirath B. Solanki, et al. Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Adults 50 to 65 years of Age in India: An Open-label Trial. Taylor & Francis Group, 2017.
Warning: These citations may not always be 100% accurate.